Cells with clonal light chains are present in peripheral blood at diagnosis and in apheretic stem cell harvests of primary amyloidosis

被引:12
作者
Perfetti, V
Ubbiali, P
Magni, M
Vignarelli, MC
Casarini, S
Matteucci, P
Gianni, AM
Merlini, G
机构
[1] Univ Pavia, Policlin San Matteo, IRCCS, Biotechnol Lab, I-27100 Pavia, Italy
[2] Univ Pavia, Policlin San Matteo, IRCCS, Organ Transplantat Res Lab, I-27100 Pavia, Italy
[3] Univ Pavia, Policlin San Matteo, IRCCS, Clin Immunol Unit, I-27100 Pavia, Italy
[4] Univ Pavia, Policlin San Matteo, IRCCS, Dept Internal Med, I-27100 Pavia, Italy
[5] Univ Pavia, Policlin San Matteo, IRCCS, Sect Internal Med & Med Oncol, I-27100 Pavia, Italy
[6] Natl Canc Inst, Div Med Oncol C, I-20133 Milan, Italy
关键词
AL amyloidosis; autologous transplantation; leukaphereses; ASO-PCR; B lymphocytes;
D O I
10.1038/sj.bmt.1701590
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
In primary systemic amyloidosis, small numbers of bone marrow plasma cells secrete monoclonal light chains that form extracellular fibrils (amyloid) in various organs. Evidence limited to a few cases suggests that rare clonal elements can also be found in the peripheral blood (PB), and this may be relevant in PB stem cell autotransplantation. Since up to 40% of amyloid clones do not synthesize heavy chains, in order to detect tumor cells with high specificity and sensitivity we developed a seminested allele-specific oligonucleotide polymerase chain reaction for tumor light chains. Clone-related sequences were detected in DNA and/or cDNA from the PB cells of eight of 10 patients at diagnosis and from apheretic collections of three of four cases undergoing PB progenitor autotransplantation. Since there are experimental data suggesting that circulating tumor cells may be involved in the growth of the amyloidogenic clone and may be chemoresistant, these findings are relevant to the use of leukapheresis purging strategies for PB progenitor autotransplantation in amyloidosis.
引用
收藏
页码:323 / 327
页数:5
相关论文
共 25 条
[1]   Saporin, a ribosome-inactivating protein used to prepare immunotoxins, induces cell death via apoptosis [J].
Bergamaschi, G ;
Perfetti, V ;
Tonon, L ;
Novella, A ;
Lucotti, C ;
Danova, M ;
Glennie, MJ ;
Merlini, G ;
Cazzola, M .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 (04) :789-794
[2]   IN MULTIPLE-MYELOMA, CLONOTYPIC B-LYMPHOCYTES ARE DETECTABLE AMONG CD19(+) PERIPHERAL-BLOOD CELLS EXPRESSING CD38, CD56, AND MONOTYPIC IG LIGHT-CHAIN [J].
BERGSAGEL, PL ;
SMITH, AM ;
SZCZEPEK, A ;
MANT, MJ ;
BELCH, AR ;
PILARSKI, LM .
BLOOD, 1995, 85 (02) :436-447
[3]   INTERLEUKIN-3 AND INTERLEUKIN-6 SYNERGISTICALLY PROMOTE THE PROLIFERATION AND DIFFERENTIATION OF MALIGNANT PLASMA-CELL PRECURSORS IN MULTIPLE-MYELOMA [J].
BERGUI, L ;
SCHENA, M ;
GAIDANO, G ;
RIVA, M ;
CALIGARISCAPPIO, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (02) :613-618
[4]   Sequential analysis of bone marrow and peripheral blood after stem cell transplant for myeloma shows disparate tumor involvement [J].
Billadeau, D ;
Prosper, F ;
Verfaillie, C ;
Weisdorf, D ;
VanNess, B .
LEUKEMIA, 1997, 11 (09) :1565-1570
[5]  
Billadeau D, 1996, BLOOD, V88, P289
[6]  
CALIGARISCAPPIO F, 1991, BLOOD, V77, P2688
[7]   Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: One-year follow-up in five patients [J].
Comenzo, RL ;
Vosburgh, E ;
Simms, RW ;
Bergethon, P ;
Sarnacki, D ;
Finn, K ;
Dubrey, S ;
Faller, DV ;
Wright, DG ;
Falk, RH ;
Skinner, M .
BLOOD, 1996, 88 (07) :2801-2806
[8]   Mobilized CD34+ cells selected as autografts in patients with primary light-chain amyloidosis: rationale and application [J].
Comenzo, RL ;
Michelle, D ;
LeBlanc, M ;
Wally, J ;
Zhang, Y ;
Kica, G ;
Karandish, S ;
Arkin, CF ;
Wright, DG ;
Skinner, M ;
McMannis, J .
TRANSFUSION, 1998, 38 (01) :60-69
[9]  
Comenzo RL, 1998, BLOOD, V91, P3662
[10]  
DELARUBIA J, 1994, BONE MARROW TRANSPL, V14, P475